ENPP2 and ovarian cancer: Our findings highlight that high expression levels of ascitic ATX correlate with poor prognosis of patients with ovarian cancer and that using ascitic ATX and serum CA125 levels as a combined biomarker showed better predictive diagnosis and prognosis power than serum CA125 levels alone.